What's Missing? Discussing Stem Cell Translational Research in Educational Information on Stem Cell "Tourism"

Journal of Law, Medicine and Ethics

Volumn 41, Issue 1, 2013, Pages 254-268

  Master, Zubin ^a   Zarzeczny, Amy ^b   Rachul, Christen ^c   Caulfield, Timothy ^d  

^a ALBANY MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF REGINA   (Canada)

^c CARLETON UNIVERSITY   (Canada)

^d UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HEALTH EDUCATION; HUMAN; MEDICAL TOURISM; STEM CELL TRANSPLANTATION; TRANSLATIONAL RESEARCH;

HEALTH EDUCATION; HUMANS; MEDICAL TOURISM; STEM CELL TRANSPLANTATION; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84876990252     PISSN: 10731105     EISSN: 1748720X     Source Type: Journal    
DOI: 10.1111/jlme.12017     Document Type: Article

References (121)

1. C. Rachul, "'What Have I Got to Lose?' An Analysis of Stem Cell Therapy Patients' Blogs," Health Law Review 20, no. 1 (2011): 5-12.
2. H. Chen and H. Gottweis, "Stem Cell Treatments in China: Rethinking the Patient Role in the Global Bio-Economy," Bioethics (2011).
3. K. A. Ryan, A. M. Sanders, D. D. Wang, and A. D. Levine, "Tracking the Rise of Stem Cell Tourism," Regenerative Medicine 5, no. 1 (2010): 27-33.
4. A. Zarzeczny and T. Caulfield, "Stem Cell Tourism and Doctors' Duties to Minors," American Journal of Bioethics 10, no. 5 (2010): 3-15.
5. A. Zarzeczny, C. Rachul, and T. Caulfield, "The Phenomenon of Stem Cell Tourism,"Atala, ed., Progenitor and Stem Cell Technologies and Therapies: Principles and Issues, vol. 1 (Cambridge, U.K.: Woodhead Publishing, 2012): at 206-233.
6. A. Regenberg, L. Hutchinson, B. Schanker, and D. Mathews, "Medicine on the Fringe: Stem Cell-Based Interventions in Advance of Evidence," Stem Cells 27, no. 9 (2009): 2312-2319.
7. O. Lindvall and I. Hyun, "Medical Innovation Versus Stem Cell Tourism," Science 324, 5935 (2009): 1664-1665.
8. D. Sipp, "Hope Alone Is Not an Outcome: Why Regulations Make Sense for the Global Stem Cell Industry," American Journal of Bioethics 10, no. 5 (2010): 33-34.
9. A. Caplan and B. Levine, "Hope, Hype and Help: Ethically Assessing the Growing Market In Stem Cell Therapies," American Journal of Bioethics 10, no. 5 (2010): 24-25.
10. S. Foster, "The Role of Patients and Patient Advocacy Groups in Educating Patients on the Importance of Legitimate Scientific Research," American Journal of Bioethics 10, no. 5 (2010): 49.
11. P. Song, "Biotech Pilgrims and the Transnational Quest for Stem Cell Cures," Medical Anthropology 29, no. 4 (2010): 384-404.
12. D. Sipp, "Stem Cell Pseudomedicine: Calling A Spade A Spade," September 5, 2011http://sctmonitor.blogspot.com/2011/09/stem-cellpseudomedicine- calling-spade.html.
13. A. Zarzeczny, C. Rachul, M. Nisbet, and T. Caulfield, "Stem Cell Clinics in The News," Nature Biotechnology 28, no. 12 (2010): 1243-1246.
14. D. Lau, U. Ogbogu, B. Taylor, T. Stafinski, D. Menon, and T. Caulfield, "Stem Cell Clinics Online: The Direct-to-Consumer Portrayal of Stem Cell Medicine," Cell Stem Cell 3, no. 6 (2008): 591-594.
15. N. Amariglio, A. Hirshberg, B.W. Scheithauer, Y. Cohen, R. Loewenthal, and L. Trakhtenbrot et al., "Donor-Derived Brain Tumor Following Neural Stem Cell Transplantation in an Ataxia Telangiectasia Patient," PLoS Medicine 6, no. 2 (2009): e10000029.
16. N. Miller, "Stem Cell Therapy Sees Man "Infected" With Cancer," November 22, 2009,http://www.watoday.com.au/national/stem-cell-therapy- sees-man-infected-with-cancer-20091123-itch.html.
17. B. Dobkin, A. Curt, and J. Guest, "Cellular Transplants in China: Observational Study from the Largest Human Experiment in Chronic Spinal Cord Injury," Neurorehabilitation and Neural Repair 20, no. 1 (2006): 5-13.
18. E. Barclay, "Stem-Cell Experts Raise Concerns about Medical Tourism," The Lancet 373, no. 9667 (2009): 883-884.
19. D. Thirabanjasak, K. Tantiwongse, and P. Thorner, "Angiomyeloproliferative Lesions Following Autologous Stem Cell Therapy," Journal of the American Society of Nephrology 21, no. 7 (2010): 1218-1222.
20. G. Vogel, "Authorities Shut Controversial German Stem Cell Clinic," Science Insider, May 10, 2011http://news.sciencemag.org/scienceinsider/2011/05/authoritiesshut- controversial-g.html?rss=1.
21. R. Mendick and A. Palmer, "Baby Death Scandal at Stem Cell Clinic Which Treats Hundreds of British Patients a Year," October 23, 2010, The Telegraph, available at http://www.telegraph.co.uk/news/worldnews/europe/germany/8082935/Baby-death-scandal-at-stem-cell-clinicwhich- treats-hundreds-of-British-patients-a-year.html.
22. R. Mendick and A. Hall, "Europe's Largest Stem Cell Clinic Shut Down after Death of Baby," May 8, 2011http://www.telegraph. co.uk/news/worldnews/europe/germany/8500233/Europeslargest- stem-cell-clinic-shut-down-after-death-of-baby.html.
23. D. Cyranoski, "Korean Deaths Spark Inquiry," Nature 468, no. 7323 (2010): 485.
24. D. Cyranoksi, "Stem-Cell Therapy Faces More Scrutiny In China," Nature 459, no. 7244 (2009): 146-147.
25. R. Carrol, "Costa Rican Health Ministry Bans Experimental Stem Cell Treatment," The Guardian, http://www.guardian.co.uk/world/2010/jun/07/costa-rica-stem-celltreatment.
26. K. Than, "Hungary Detains 4 over Illegal Stem Cell Treatment," Reuters, available athttp://www.reuters.com/article/2009/07/29/us-hungary-stemcell-idUSTRE56S4PR2009 0729?pageNumber=1virtualBrandChannel=0.
27. S. Sung-sik and M. Gwang-lip, "RNL Bio Probed Over Stem Cell Treatments," Korea Joongang Daily, http://koreajoongangdaily.joinsmsn.com/news/article/article. aspx?aid=2930548.
28. J. Yee, "Dominican Authorities Warn Stem Cell Treatments Are Illegal," BioEdge,http://www.bioedge.org/index. php/bioethics/bioethics_article/9559/.
29. Dominican Today, "Stem Cell Treatments Illegal, Dominican Authorities Warn," Dominican Todayhttp://www.dominicantoday.com/dr/local/2011/5/24/39647/stem-cell-treatments-illegal-domincanauthorities-warn.
30. D. Cyranoski, "China's Stem-Cell Rules Go Unheeded," Nature 484, no. 7393 (2012): 149-150.
31. V. Ward, "Stem Cell Doctor Robert Trossel Struck Off Medical Register," September 30, 2010http://www.telegraph.co.uk/health/healthnews/8033130/Stem-cell-doctor-Robert-Trossel-struck-off-medical-register. html.
32. State of Florida, Department of Health. Final Order No. DOH-11-473-ERO0MGA, File Date February 22, 2011, Case Number: 2010-14317.
33. D. Cyranoski, "FDA Challenges Stem-Cell Clinic," Nature 466, no. 7309 (2010): 909.
34. T. Lysaght and A. Campbell, "Regulating Autologous Adult Stem Cells: The FDA Steps Up," Cell Stem Cell 9, no. 5 (2011): 393-396.
35. B. von Tigerstrom, "The Food and Drug Administration, Regenerative Sciences, and the Regulation of Autologous Stem Cell Therapies," Food and Drug Law Journal 66 (2011): 479-506.
36. J. Blevins, "Stem-Cell Therapy Feels Food and Drug Administration's Pinch," April13, 2010, Denver Post, available at http://www.denverpost.com/news/ci_14871656.
37. Federal Bureau of Investigation, San Antonio Division, U.S. Attorney's Office(a), Press Release, Owner of Arizona Company Charged and Convicted of Introducing an Unapproved New Drug - Stem Cells - into Interstate Commerce (August 18, 2011http://www.fbi.gov/sanantonio/press-releases/2011/owner-of-arizona-company-chargedand- convicted-of-introducing-an-unapproved-new-drugstem- cells-into-interstate-commerce.
38. Federal Bureau of Investigation, San Antonio Division, U.S. Attorney's Office(b), Federal Indictments Lead to Arrests in Stem Cell Case, Press Release, December 28, 2011, available at http://www.fbi.gov/sanantonio/pressreleases/2011/federal-indictments-lead-to-arrests-in-stemcellcase.
39. E. Callaway, "American Scientist Arrested In Stem-Cell Clinic Sting," 2011, http://blogs. nature.com/news/2011/12/american-scientist-arrested-instem- cell-clinic-sting.html.
40. B. Furlow, "Arrests in the USA Over Unapproved Stem-Cell Therapies," The Lancet Oncology 13, no. 2 (2012): 55.
41. Z. Master and U. Ogbogu, "Stem Cell Tourism in the Era of Personalized Medicine: What We Know, and What We Need to Know," Current Pharmacogenomics and Personalized Medicine 10, no. 2 (2012): 106-110.
42. International Society for Stem Cell Research (ISSCR), Patient Handbook on Stem Cell Therapies, December3, 2008http://www.isscr.org/clinical_trans/pdfs/ISSCRPatientHandbook. pdf.
43. International Society for Stem Cell Research (ISSCR), "A Closer Look at Stem Cellshttp://www.closerlookatstemcells. org//AM/Template.cfm?Section=Home1.
44. Australian Stem Cell Centre, "Stem Cell Therapies: Now and In The Future - The Australian Stem Cell Centre Patient Handbook," 2009, available athttp://www.msnz.org.nz/Document.Doc?id=23.
45. UKSCN, UKSCN Position Statement on Stem Cell Tourism, available at http://www.uknscn.org/downloads/stem_cell_ tourism.pdf2013.
46. Stem Cell Network, "Stem Cell Hype and The Dangers Of Stem Cell 'Tourismat http://www.stemcellnetwork.ca/index. php?page=stem-cell-hype-and-the-dangers-of-stem-cell-tourism.
47. Parkinson Society Canada, Stem Cell Research and Parkinson's Disease, 2009, available at http://www.parkinson.ca/atf/cf/%7B9EBD08A9-7886-4B2D-A1C4-A131E7096BF8%7D/stem%20cells%20-%20en.pdf.
48. Australia New Zealand Spinal Cord Injury Network, Stem Cell Interventions for Spinal Cord Injury, 2009, available athttp://www.stemcellcentre.edu.au/site/DefaultSite/filesystem/documents/For%20the%20Public/ANZSCIN%20 Stem%20Cell%20Interventions%20for%20Spinal%20 Cord%20Injury.pdf.
49. MS Society (U.K.), MS Society Scotland, MS Society Cymru, MS Society Northern Ireland, Stem Cell Therapies in MS, 2010http://www.mssociety.org.au/documents/Stem- CellBooklet.pdf.
50. ALSUntangled Group, "ALSUntangled Update 4: Investigating the XCell-Center," Amyotrophic Lateral Sclerosis 11, no. 3 (2010): 337-338.
51. Z. Master and D. B. Resnik, "Stem Cell Tourism and Scientific Responsibility," EMBO Reports 12, no. 10 (2011): 992-995.
52. J. Kitzinger and C. Williams, "Forecasting Science Futures: Legitimising Hope and Calming Fears in the Embryo Stem Cell Debate," Social Science and Medicine 61, no. 3 (2005): 731-740.
53. L. P. Knowles, Stem Cell Hype and the Dangers Of Stem Cell 'Tourism,' 2009, Ethics White Paper for the Stem Cell Network, http://www.stemcellnetwork.ca/uploads/File/whitepapers/Stem-Cell-Hype.pdf.
54. The cover of this magazine can be found in Time Magazine, How the Coming Revolution in Stem Cells Could Save Your Life, February 9, 2009http://www.time.com/time/covers/0,16641,20090209,00.html.
55. The cover of this magazine can be found in The Economist, "Cancer and Stem Cells: The Connection That Could Lead to a Cure," September 13, 2008, available at http://www.economist. com/printedition/2008-09-13.
56. A. Coghlan, "Stem-Cell Find Breathes New Life Into Lung Repair," 2011, http://www.newscientist.com/article/dn21102-stemcell-findbreathes- new-life-into-lung-repair.html.
57. A. Coghlan, "Brain Cells Made From Skin Could Treat Parkinson's," New Scientist, July 6, 2011http://www.newscientist.com/article/dn20659-brain-cellsmade- from-skin-could-treat-parkinsons.html?DCMP=OTCrssnsref=online-news.
58. T. E. Lyn, "Stem Cell Team Aims For Spare Heart Parts In Five Years," August 18, 2011http://www. reuters.com/article/2011/08/18/us-heart-stemcells-idUSTRE77H0ZM20110818.
59. International Society for Stem Cell Research (ISSCR), Guidelines for the Clinical Translation of Stem Cells, December 3, 2008http://www.isscr.org/clinical_trans/pdfs/ISSCRGLClinicalTrans.pdf.
60. E. A. Rayment and D. J. Williams, "Concise Review: Mind the Gap: Challenges in Characterizing and Quantifying Cell- and Tissue-Based Therapies for Clinical Translation," Stem Cells 28, no. 5 (2010): 996-1004.
61. A. Knight, "Systematic Reviews of Animal Experiments Demonstrate Poor Contribution Towards Human Healthcare," Reviews on Recent Clinical Trials 3, no. 2 (2008): 89-96.
62. E. S. Sena, H. B van der Worp, P. M. W. Bath, D. W. Howells, and M. R. Macleod, "Publication Bias in Reports of Animal Stroke Studies Leads to Major Overstatement of Efficacy," PLoS Biology 8, no. 3 (2010):e1000344.
63. J. Weaver, "Animal Studies Paint Misleading Picture," Scientific American 2010 http://www.scientificamerican.com/article.cfm?id=animal-studies-paint-misleading.
64. D. Halme and D. Kessler, "FDA Regulation of Stem-Cell- Based Therapies," New England Journal of Medicine 355, no. 16 (2006): 1730-1735.
65. K. C. Glass, C. Weijer, D. Cournoyer, T. Lemmens, R. M. Palmour, and S. H. Shapiro et al., "Structuring the Review of Human Genetics Protocols, Part III: Gene Therapy Studies, 21, no. 2 (1999): 1-9.
66. Z. Master, M. McLeod, and I. Mendez, "Benefits, Risks and Ethical Considerations in Translation of Stem Cell Research to Clinical Applications in Parkinson's Disease," Journal of Medical Ethics 33, no. 3 (2007): 169-173.
67. D. W. Fink, Jr., "FDA Regulation of Stem Cell-Based Products," Science 324, no. 5935 (2009): 1162-1163.
68. J. Wilson, "A History Lesson for Stem Cells," Science 324, no. 5928 (2009): 727-728.
69. 21 C.F.R. 312.21.
70. ClinicalTrials.gov, "Understanding Clinical Trials," available at http://clinicaltrials.gov/ct2/info/understand.
71. R. Levine, Ethics and Regulation of Clinical Research (New Haven: Yale University Press, 1986):.
72. Food and Drug Administration, "Tissue and Tissue Product Questions and Answers," available ahttp://www.fda.gov/BiologicsBloodVaccines/TissueTissueProducts/default.htm.
73. C.F.R. 1270.
74. C.F.R. 1271.
75. Canadian Institutes of Health Research, "Updated Guidelines for Human Pluripotent Stem Cell Research, June 30, 2010," http://www.cihr-irsc.gc.ca/e/42071.html.
76. M. Wadman, "The Bridge between Lab and Clinic," Nature 468, no. 7326 (2010): 877.
77. J. C. Reed, E. L. White, J. Aubé, C. Lindsley, M. Li, L. Sklar, and S. Schreiber, "The NIH's Role in Accelerating Translational Sciences," Nature Biotechnology 30, no. 1 (2012): 16-19.
78. A. Pollack, "Geron Is Shutting Its Stem Cell Clinical Trial," New York Times, http://www. nytimes.com/2011/11/15/business/geron-is-shutting-down-itsstem- cell-clinical-trial.html.
79. V. Prasad, A. Cifu, and J. P. A. Ioannidis, "Reversals of Established Medical Practices. Evidence to Abandon Ship," JAMA 307, no. 1 (2012): 37-38.
80. J. Kaiser, "Embryonic Stem Cells Appear Safe, May Help Eye Disease," Science Now, January 23, 2012http://news.sciencemag.org/sciencenow/2012/01/embryonic-stemcells- appear-safe.html?ref=emelq=e8ec8290ab0a4cc38cf5c 72130ffdcad.
81. S. D. Schwartz, J. P. Hubschman, G. Heilwell, V. Franco-Cardenas, and C. K. Pan et al., "Embryonic Stem Cell Trials for Macular Degeneration: A Preliminary Report," The Lancet 379, no. 9817 (2012): 713-720.
82. H. Jung and Y. Hyun-young, "South Korea Back in Stem Cell Spotlight with New Treatment," Reuters, 2011, http://www.reuters.com/article/2011/07/07/us-koreastemcell- idUSTRE76610C20110707.
83. S. Reinberg, "Stem-Cell Trial Failed to Treat Heart Failure," HealthDayhttp://consumer. healthday.com/Article.asp?AID=663058.
84. S. Parke and J. Illes, "In Delicate Balance: Stem Cells and Spinal Cord Injury Advocacy," Stem Cell Reviews and Reports 7, no. 3 (2011): 657-663.
85. International Society for Stem Cell Research (ISSCR), "Top Ten Things to Know about Stem Cell Treatments," at Fact #5http://www.closerlookatstemcells.org/Top_10_ Stem_Cell_Treatment_Facts.htm.
86. International Society for Stem Cell Research (ISSCR), "How Science Becomes Medicinehttp://www.closerlookatstemcells. org/How_Science_Becomes_Medicine.htm.
87. How Clinical Trials Work, http://www.closerlookatstemcells.org/Clinical_Trials.htm.
88. Australian Stem Cell Centre, Stem Cell Therapies: Now and in the Future. The Australian Stem Cell Centre Information Handbook, April 2011http://www.stemcellcentre. edu.au/For_the_Public/Patient/Handbook.aspx.
89. Food and Drug Administration, FDA Seeks Injunction Against Colorado Manufacturer of Cultured Cell Product, FDA News Release, August 6, 2010http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm221656. htm.
90. S. Fox and D. Fallows, "Internet Health Resources," Pew Internet American Life Project (2003), 1-35http://papers.ssrn.com/sol3/papers.cfm?abstract_id=2054071.
91. L. Baker, T. H. Wagner, S. Singer, and M. K. Bundorf, "Use of the Internet and E-mail for Health Care Information: Results From a National Survey," JAMA 289, no. 18 (2003): 2400-2406.
92. C. Tuffrey and F. Finlay, "Use of the Internet by Parents of Paediatric Outpatients," Archives of Disease in Childhood 87, no. 6 (2002): 534-536.
93. B. K. Wainstein, K. Sterling-Levis, S. A. Baker, J. Taitz, and M. Brydon, "Use of the Internet by Parents of Paediatric Patients," Journal of Paediatrics and Child Health 42, no. 9 (2006): 528-532.
94. J. A. Diaz, R. A. Griffith, J. J. Ng, S. E. Reinert, and P. D. Friedmann et al., "Patients' Use of the Internet for Medical Information," Journal of General Internal Medicine 17, no. 3 (2002): 180-185.
95. B. W. Hesse, D. E. Nelson, G. L. Kreps, R. T. Croyle, and N. K. Arora et al., "Trust and Sources of Health Information," Archives of Internal Medicine 165, no. 22 (2005): 2618-2624.
96. N. C. Di Pietro, L. Whiteley, A. Mizgalewicz, and J. Illes, "Treatment of Neurodevelopmental Disorders: Evidence, Advocacy, and the Internet," Journal of Autism and Developmental Disorders 43, no. 1 (2012): 122-133.
97. D. Schillinger, K. Grumbach, J. Piette, F. Wang, and D. Osmond et al., "Association of Health Literacy with Diabetes Outcomes," JAMA 288, no. 4 (2002): 475-482.
98. S. L. Janson, J. V. Fahy, J. K. Covington, S. M. Paul, and W. M. Gold et al., "Effects of Individual Self-Management Education on Clinical, Biological, and Adherence Outcomes in Asthma," American Journal of Medicine 115, no. 8 (2003): 620-626.
99. A. L. Wong, J. O. Harker, V. P. Lau, S. Shatzel, and L. H. Port, "Spanish Arthritis Empowerment Program: A Dissemination and Effectiveness Study," Arthritis Rheumatism 51, no. 3 (2004): 332-336.
100. T. Nijsten, T. Rolstad, S.R. Feldman, and R. S. Stern, "Members of the National Psoriasis Foundation: More Extensive Disease and Better Informed about Treatment Options," Archives of Dermatology 141, no. 1 (2005): 19-26.
101. D. Nielsen, J. Ryg, N. Nissen, W. Nielsen, and B. Knold et al., "Multidisciplinary Patient Education in Groups Increases Knowledge on Osteoporosis: A Randomized Controlled Trial," Scandinavian Journal of Public Health 36, no. 4 (2008): 346-352.
102. M. Emtner, A. Hedin, M. Andersson, and C. Janson, "Impact of Patient Characteristics, Education and Knowledge on Emergency Room Visits in Patients with Asthma and COPD: A Descriptive and Correlative Study," BMC Pulmonary Medicine 9, (2009): 43.
103. G. Makoul, K. A. Cameron, D. W. Baker, L. Francis, and D. Scholtens et al., "A Multimedia Patient Education Program on Colorectal Cancer Screening Increases Knowledge and Willingness to Consider Screening Among Hispanic/Latino Patients," Patient Education and Counseling 76, no. 2 (2009): 220-226.
104. M. Surjadi, C. Torruellas, C. Ayala, H. F. Yee, Jr., and M. Khalili, "Formal Patient Education Improves Patient Knowledge of Hepatitis C in Vulnerable Populations," Digestive Diseases and Sciences 56, no. 1 (2011): 213-219.
105. J. R. Durant, G. A. Evans, and G. P. Thomas, "The Public Understanding of Science," Nature 340, no. 6228 (1989): 11-14.
106. G. Evans and T. Durant, "The Relationship Between Knowledge and Attitudes in the Public Understanding of Science in Britain," Public Understanding of Science 4, no. 1 (1995): 57-74.
107. G. Thomas and J. Durant, "Why Should We Promote The Public Understanding Of Science?" Science Literacy Papers 1, (1987): 1-14http://www.core.org.cn/NR/rdonlyres/Science-Technology-and-Society/STS-014Spring-2006/2737FE74-34D6-4A16-A7DD-95F0FBE60BA0/0/durant_promote.pdf.
108. C. Mooney, Do Scientists Understand The Public? (Cambridge: American Academy of Arts and Sciences, 2010http://www.amacad.org/pdfs/scientistsUnderstand.pdf.
109. M. C. Nisbet and R. K. Goidel, "Understanding Citizen Perception of Science Controversy: 5Bridging the Ethnographic-Survey Research Divide," Public Understanding of Science 16, no. 4 (2007): 421-440.
110. S. H. Priest, "Misplaced Faith: Communication Variables as Predictors of Encouragement for Biotechnology Development," Science Communication 23, no. 2 (2001): 97-110.
111. M. Siegrist, "The Influence of Trust and Perceptions of Risks and Benefits on the Acceptance of Gene Technology," Risk Analysis 20, no. 2 (2000): 195-203.
112. M. Siegrist and G. Cvetkovich, "Perception of Hazards: The Role of Social Trust and Knowledge," Risk Analysis 20, no. 5 (2000): 713-719.
113. J. Turney, "Public Understanding of Science," The Lancet 347, no. 9008 (1996): 1087-1090.
114. J. Ziman, "Public Understanding of Science," Science, Technology, and Human Values 16, no. 1 (1991): 99-105.
115. S. H. Priest, H. Bonfadelli, and M. Rusanen, "The 'Trust Gap' Hypothesis: Predicting Support for Biotechnology Across National Cultures as a Function of Trust in Actors," Risk Analysis 23, no. 4 (2003): 751-766.
116. C. R. Critchley, "Public Opinion and Trust in Scientists: The Role of the Research Context, and the Perceived Motivation of Stem Cell Researchers," Public Understanding of Science 17, no. 3 (2008): 309-327.
117. H. Liu and S. Priest, "Understanding Public Support for Stem Cell Research: Media Communication, Interpersonal Communication and Trust in Key Actors," Public Understanding of Science 18, no. 6 (2009): 704-718.
118. Wellcome Trust, "Information And Attitudes: Consulting the Public about Biomedical Science," 2005, available athttp://www.wellcome.ac.uk/About-us/Publications/Reports/Publicengagement/WTX026430.htm.
119. E. Einsiedel and H. Adamson, "Stem Cell Tourism and Future Stem Cell Tourists: Policy and Ethical Implications," Developing World Bioethics 12, no. 1 (2012): 35-44.
120. In recognition of these and other potential challenges, we have designed a new public outreach initiative with the support of the Canadian Stem Cell Network. This initiative will produce a patient handbook that will be widely disseminated, including to the organizations included in our study examining online educational information on stem cell tourism, discussed above.
121. Z. Master and D. B. Resnik, "Hype and Public Trust in Science," Science and Engineering Ethics (2011).